Skip to main content

Chimeric Antigen Receptor (CAR) T-cell Therapy

CAR T-cell Therapy Referrals

Standard of care CAR T-cell therapy is available within BC in a limited capacity, alongside a select number of sites within Canada upon approval. Referrals must be sent to

Please note, all documents on this webpage are provided for clinician-use only. 


CAR T Patient Referrals (Adults)

To initiate a CAR T referral for a patient:

  • Please complete the BC Cancer CAR T-cell Referral Form, ensuring the patient meets the CAR T eligibility criteria for the specific indication. 
  • Please include a summary letter/clinical note of the patient’s treatment course to date; and other relevant consult and clinical notes, as described in the referral form.

Once completed, email the referral package to

*BC Ministry of Health funded indications and patients who meet eligibility criteria will only be approved. 

The BC Cancer Provincial Virtual Oncology Nursing Team will coordinate the handling of the referral, including assessing in-province and out-of-province capacity and completing/submitting the CAR T treatment centre's referral form. They will update the referring provider as the referral is reviewed, adjudicated, and treatment site is determined. 

*If there are any tests supporting a referral that are missing/outdated, it is the referring provider's responsibility to arrange for these tests. The BC Cancer Provincial Virtual Oncology Nursing Team will contact the referring provider if this is the case. 

For any questions, or to submit a referral, please contact:

Pediatric CAR T-cell Therapy

For patients under 18, please refer to Blood & Bone Marrow Transplant at BC Children's Hospital.


For more information on adult CAR T-cell therapy referrals, please consult the Frequently Asked Questions resource.

Post CAR T-cell Therapy

Post CAR T-cell Therapy 

Following discharge from the CAR T-cell therapy treatment centre, post-CAR T-cell therapy management will be the responsibility of the referring providers and their care teams. The BC Cancer Provincial Virtual Oncology Nursing Team cannot arrange any testing for patients. Please refer to the BC Cancer Post CAR T Guidelines and the BCCDC Post CAR T Immunization Guidelines for further information.

*Please note, the BC Cancer Provincial Virtual Oncology Nursing Team will contact patients at 3-months post-treatment to notify them of the BCCCDC post-CAR T immunization recommendation and provide the immunization worksheet for completion through their local public health unit. The team will also contact providers at 24-months to remind them of the recommendation for IgG testing following MMR vaccination. The above is applicable to in-province and out-of-province patients.

Tab Heading

Tab Heading

SOURCE: Chimeric Antigen Receptor (CAR) T-cell Therapy ( )
Page printed: . Unofficial document if printed. Please refer to SOURCE for latest information.

Copyright © BC Cancer. All Rights Reserved.

    Copyright © 2024 Provincial Health Services Authority